Clinical Trial Update: Patient-Derived Xenograft (PDX) Modeling in Adult Patients With Metastatic or Recurrent Sarcoma [NA]

View source ↗

Summary

A clinical trial evaluating patient-derived xenograft modeling in adults with metastatic or recurrent sarcoma was terminated. No efficacy results are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Snippet

Sponsor: Champions Oncology | Conditions: Sarcoma | NA | Status: TERMINATED